How many doses are there in the imported 13-valent pneumococcal vaccine?
The 13-valent pneumococcal vaccine refers to the 13-valent pneumococcal polysaccharide conjugate vaccine. The imported 13-valent pneumococcal polysaccharide conjugate vaccine typically requires four doses, which should be administered under professional medical guidance.
The imported 13-valent pneumococcal polysaccharide conjugate vaccine is suitable only for children aged from 6 weeks to 15 months. The injections are generally given at 2 months, 4 months, 6 months, and 18 months of age, totaling four doses, with each dose spaced 4 to 8 weeks apart. Pneumonia is a relatively serious disease; if not treated promptly, it may worsen and lead to complications such as encephalitis, posing significant risks to health. Therefore, timely administration of the pneumococcal vaccine to children is essential to reduce the risks associated with pneumonia. Additionally, the imported 13-valent pneumococcal polysaccharide conjugate vaccine uses CRM197 protein as a carrier and provides preventive protection against pneumonia caused by 13 serotypes of encapsulated pneumococcal bacteria.
After vaccination, parents should closely monitor their child's condition and seek immediate medical attention if any adverse reactions occur.